Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation (Tailored-AF)
Sponsor: CardiaBase
Listed as NCT04702451, this NA trial focuses on Atrial Fibrillation and remains completed. Sponsored by CardiaBase, it has been updated 14 times since 2021, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
14 versions recorded-
Oct 2025 — Present [monthly]
Completed NA
-
Sep 2025 — Oct 2025 [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2024 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 9 earlier versions
-
Mar 2023 — May 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2022 — Mar 2023 [monthly]
Recruiting NA
-
Feb 2022 — Jun 2022 [monthly]
Recruiting NA
-
Nov 2021 — Feb 2022 [monthly]
Recruiting NA
-
Oct 2021 — Nov 2021 [monthly]
Recruiting NA
-
Sep 2021 — Oct 2021 [monthly]
Recruiting NA
-
Apr 2021 — Sep 2021 [monthly]
Recruiting NA
-
Mar 2021 — Apr 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2021 — Mar 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- CardiaBase
- Fortrea
- Volta Medical
For direct contact, visit the study record on ClinicalTrials.gov .